🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Alcohol Use Disorder (AUD)

Virtual Reality (VR) NATURE - Alcohol Use Disorder (AUD) NCT07413458NA1 site📍 Ann Arbor University of Michigan · Tests: Virtual Reality (VR) -nature treatment, Survey completion Combining a Smartphone App With Medications to Manage Heavy Drinking NCT06303778NA15 sites📍 Phoenix📍 Fayetteville📍 Washington D.C. VA Office of Research and Development · Tests: Stand Down mobile app, Standard Care TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) NCT07171359NA1 site📍 Portland Washington State University · Tests: TMS Low-Dose, TMS High-Dose Neural and Hormonal Influences on Sex Differences in Risk for AUD NCT04929288NA1 site📍 Columbus Jessica Weafer · Tests: Alcohol Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers NCT06136195Phase 12 sites📍 New Haven📍 New Haven Yale University · Tests: Mavoglurant Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma NCT06278922NA1 site📍 Worcester University of Massachusetts, Worcester · Tests: Seeking Safety + Signs of Safety toolkit, Treatment as usual Sensory and Physical Reactions to Beverage Cues NCT07788716NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Alcohol Cue Reactivity Paradigm Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment NCT07342504NA1 site📍 Notre Dame University of Notre Dame · Tests: Brief opioid-informed alcohol treatment The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) NCT06070649Phase 11 site📍 New Haven Yale University · Tests: 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion, 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion, 25… Anxiety During Abstinence in AUD NCT06793488EARLY Phase 11 site📍 New York Columbia University · Tests: Disulfiram 250 mg, functional MRI Alcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study Employing a Within-Subject Design NCT07125534NA2 sites📍 Champaign📍 Champaign University of Illinois at Urbana-Champaign · Tests: Alcohol beverage, Control - non alcoholic beverage Deep Brain Stimulation to Understand and Treat Addiction NCT07341230NA2 sites📍 Cambridge📍 London University of Cambridge · Tests: Dual-Target Deep Brain Stimulation, Nucleus Accumbens Deep Brain Stimulation, Ventral Internal Capsule Deep Brain Stimu… Imaging CRF X NOP Interactions in Alcohol Use Disorder NCT07612631EARLY Phase 11 site📍 Pittsburgh Rajesh Narendran · Tests: Baseline [C-11]NOP-1A PET scan, Hydrocortisone, Post-hydrocortisone [C-11]NOP-1A PET scan Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder NCT07405606Phase 21 site📍 Toronto Centre for Addiction and Mental Health · Tests: Psilocybin 25 mg, Placebo High Intensity Alternating Current Stimulation as a Neuromodulation Therapy for Alcohol Use Disorder: A Pilot Study NCT07227545NA1 site📍 Shanghai Shanghai Mental Health Center · Tests: HI-tACS Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism NCT07824089NA1 site📍 Cleveland The Cleveland Clinic · Tests: Endurance Exercise Identification and Molecular Characterisation of Urban-environmental Stress Patterns Affecting Mental Illness NCT07571226n/a3 sites📍 Beijing📍 Shanghai📍 Shanghai Huashan Hospital · Tests: wearable monitoring devices Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD) NCT07525258NA1 site📍 New Haven Yale University · Tests: Implementation Intervention Tdcs And cogNitive traininG cOmbined for AUD (TANGO) NCT05062369NA1 site📍 Minneapolis University of Minnesota · Tests: TaskFlow Transcranial Electrical Stimulation device, Executive Function Focused Cognitive Training The Impact of Heavy Alcohol Use on Saliva and Oral Health NCT06684483n/a1 site📍 Bethesda National Institutes of Health Clinical Center (CC) Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD) NCT06648642NA1 site📍 San Antonio The University of Texas Health Science Center at San Antonio · Tests: Transcranial Magnetic Stimulation (TMS) Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B) NCT07027839Phase 11 site📍 Bethesda National Institute of Mental Health (NIMH) · Tests: Intravenous Ethanol, 18F-PF-06445974 Study of Tirzepatide for Recovery and Alcohol Use Management NCT06727331Phase 22 sites📍 Boston📍 Jamaica Plain Brigham and Women's Hospital · Tests: Tirzepatide, Saline Placebo Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection NCT06139224NA1 site📍 Chicago Rush University Medical Center · Tests: 4 week prebiotic consumption, 4 week placebo consumption Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder NCT07071779NA1 site📍 Bern University of Bern · Tests: Substance-specific inhibition training, Control training Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients NCT06269510NA1 site📍 Detroit Henry Ford Health System · Tests: ENGAGE-ALD Application (APP), Treatment Facilitation bundle, Enhanced Usual Care Probenecid Administration for Alcohol Craving and Consumption NCT07118618Phase 21 site📍 Providence Brown University · Tests: Probenecid Oral Tablet, Placebo Oral Tablet Attentional Control Training for Treating Alcohol Use Disorder NCT05102942NA1 site📍 Valby University of Southern Denmark · Tests: Attentional Control Training Program Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving NCT07148843Phase 2, Phase 31 site📍 Baltimore Johns Hopkins University · Tests: Cannabidiol (CBD), Placebo Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking NCT05181891Phase 21 site📍 Spokane Washington State University · Tests: Contingency Management, Non-contingent control
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy